Loading...

Expression analysis of BDNF, BACE1 and their antisense transcripts in inflammatory demyelinating polyradiculoneuropathy

Ghafour Fard, S ; Sharif University of Technology | 2021

420 Viewed
  1. Type of Document: Article
  2. DOI: 10.1016/j.msard.2020.102613
  3. Publisher: Elsevier B.V , 2021
  4. Abstract:
  5. Acute and chronic inflammatory demyelinating polyradiculoneuropathies (AIDP and CIDP) are two immune-related conditions in the peripheral nervous system. In the current study, we assessed expression levels of Beta-secretase (BACE1), brain-derived neurotrophic factor (BDNF) and their antisense transcripts in the peripheral blood of AIDP and CIDP patients compared with age- and sex-matched controls to assess their potential as biomarkers for these conditions. Expressions of BACE1 and BACE1-AS were down-regulated in CIDP cases compared with controls (Ratios of mean expressions=0.01 and 0.03; P values= 1.07E-08, respectively). On the other hand, expressions of BDNF and BDNF-AS were up-regulated in CIDP cases compared with controls (Ratios of mean expressions=4.78 and 25.71; P values= 7.84E-03 and 2.66E-07, respectively). Expressions of BACE1 and BACE1-AS were lower in AIDP cases compared with controls (Ratios of mean expressions=0.00; P values= 6.92E-10 and 8.04E-10, respectively). While expression of BDNF was not different between AIDP cases and controls, expression of its antisense transcript was higher in total AIDP cases compared with total controls (Ratio of mean expression= 8.61, P value=3.69E-04). Expressions of BACE1-AS, BDNF and BDNF-AS were significantly higher in CIDP cases compared with AIDP cases (Ratios of mean expression=1.98, 3.49 and 2.99; P values=4.67E-02, 4.67E-04 and 8.94E-03 respectively). Expression levels of BACE1, BACE1-AS and BDNF-AS could distinguish AIDP and CIDP cases from healthy subjects. BACE1 had the best diagnostic values in differentiation of CIDP and AIDP cases from controls (AUC values=0.88 and 0.91, respectively). Combination of all genes enhanced the diagnostic power to 0.96, 0.97 and 0.97 for differentiation between CIDP/controls, AIDP/controls and all patients/controls, respectively. Taken together, these genes might be implicated in the pathogenesis of AIDP and CIDP and can be suggested as putative markers for these conditions. © 2020 Elsevier B.V
  6. Keywords:
  7. Beta secretase 1 ; Brain derived neurotrophic factor ; Aspartic proteinase ; BACE1 protein, human ; Secretase ; Adult ; BACE1 gene ; BDNF gene ; Blood ; Chronic inflammatory demyelinating polyradiculoneuropathy ; Controlled study ; Diagnostic value ; Disease classification ; Down regulation ; Female ; Gene expression ; Human ; Major clinical study ; Male ; Pathogenesis ; Upregulation ; Genetics ; Guillain Barre syndrome ; Polyradiculoneuropathy ; Amyloid Precursor Protein Secretases ; Aspartic Acid Endopeptidases ; Brain-Derived Neurotrophic Factor ; Guillain-Barre Syndrome ; Humans ; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  8. Source: Multiple Sclerosis and Related Disorders ; Volume 47 , 2021 ; 22110348 (ISSN)
  9. URL: https://www.sciencedirect.com/science/article/pii/S2211034820306878